Latest scientific findings on EPA, tocopherol, and updates on New Zealand’s diet study

Diabetic benefit: EPA found to reduce cardiovascular risk in patients – meta analysis​

The supplementation of eicosapentaenoic acid (EPA) has shown to lower the risk of cardiovascular diseases in diabetic patients, according to a meta-analysis conducted by Chinese researchers.

Eight randomised controlled trials involving 57,754 participants were included in the meta-analysis.

It found that omega-3 fatty acids supplementation in general had significantly reduced cardiovascular incidences in patients with diabetes. However, the risk was even lower when the patients were supplemented with EPA alone, than the combination of EPA and DHA.

‘Good for industry, good for policy’: Large scale study to assess benefits of ‘NZ diet’ on key health outcomes​  

New Zealand researchers are hoping that results from a new, large-scale dietary intervention study will underpin domestic nutrition policies and boost export opportunities.

He Rourou Whai Painga is a two-year study that aims to develop a ‘New Zealand diet,’ comprising of predominantly locally produced food and beverages, to improve the metabolic and cardiovascular health for at-risk individuals.

The two-year study – set to complete in June 2024 – involves 200 participants and families from Auckland, Christchurch, Wellington, and Kokiri Marae in Lower Hutt.

Collagen peptide reduces post-exercise muscle soreness, fatigue in middle-aged men – RCT​

The supplementation of collagen peptide has shown to reduce exercise-induced muscle soreness and fatigue in middle-aged men, making it a potential sports nutrition candidate.

This is based on a 33-day long trial involving 20 middle-aged men who were randomised to take either five grams of fish-derived collagen peptides or dextrin. On the 29th day of the trial, all of them did a maximum of five sets of 40 bodyweight squats to measure the effects of collagen supplementation on muscle soreness.

Source link